The endothelium controls the influx of macromolecules into the tissues, a process that may be disturbed at sites of inflammation and in atherosclerotic plaques. In this article, we report our evaluations of the effects of the inflammatory mediator, tumor necrosis factor-a (TNF-or), on the production of prostacyclin and the barrier function of human endothelial cell monolayers in an in vitro model. TNF-a (500 units/ml) had no direct effect on the passage of sucrose, peroxidase, and low density lipoprotein through monolayers of human aortic endothelial cells. On the other hand, during the first hours after addition 500 units/ml TNF-or induced a reduction of the permeability of umbilical artery endothelial cell monolayers. Within 10 minutes TNF-ar induced an increase in prostacyclin production by primary cultures of umbilical artery endothelial cells. However, the reduction in permeability was not caused by a change in prostacyclin production or by a change in cyclic AMP concentration because 1) the effect of TNF-« on permeability was not prevented by aspirin, 2) no change in the cellular cyclic AMP concentration could be observed after addition of TNF-oi and 3) TNF-orwas still able to reduce the passage rate in the presence of 25 fxM forskolin. The reduction in permeability was accompanied by a decrease of F-actin in stress fibers. With prolonged incubation with TNF-o^ the permeability of umbilical artery endothelial cell monolayers increased, and F-actin was found again in stress fibers. However, these effects of TNF-ar were only significant at high concentrations of TNF-«. Because high TNF-a concentrations only persist in vivo for short periods and no increase in the permeability of human aortic endothelial permeability was observed after incubation with TNF-a, it is unlikely that TNF-a plays a role in the increased permeability that has been found in human arteriosclerotic lesions. (Arteriosclerosis and Thrombosis 1991;11:872-881)
Because human atheromata contain numerous macrophages in which tumor necrosis factor-a (TNF-a) can be detected in the cytoplasm by immunohistochemical techniques 5 and endothelial cells in vitro show structural changes after incubation with TNF-a, 6 -8 we set up a series of experiments to evaluate the effect of TNF-a on endothelial permeability. We used an in vitro model that we had previously developed and characterized 910 to study the permeability of human endothelial cells. Two groups of investigators have recently reported that TNF-a increases the permeability of sheep and bovine endothelial cell monolayers on porous filters. 1112 On the other hand, the passage of albumin through human umbilical vein monolayers did not increase for as long as 4 hours after addition of TNF-a or interleukin-1 (IL-1) while the diapedesis of neutrophils did increase during the same time period. 13 In the present article, we report that high concentrations of TNF-a have a dual, time-dependent effect on the permeability of monolayers of human umbilical artery endothelial cells, whereas such concentrations of TNF-a do not increase the permeability of human aortic endothelial cell monolayers. In addition, we have evaluated whether TNF-a affects the immediate release of prostacyclin and the concentration of cyclic AMP in the cells and whether prostacyclin and cyclic AMP may be involved in the initial decrease of endothelial permeability induced by TNF-a in human umbilical artery endothelial cell monolayers.
Methods

Materials
Medium-199 supplemented with 20 mM Af-2-hydroxylethylpiperazine-iV'-2-ethanesulfonic acid (HEPES) was obtained from Flow Laboratories, Irvine, Scotland; tissue-culture plastics were from Corning Glass Works, Corning, N.Y., or Costar, Cambridge, Mass.; and Transwells (0.65-cm diameter, 3-iim pore size) were from Costar. Human recombinant TNF-a was a gift from Jan Tavernier, Biogent, Gent, Belgium. The preparation contained 2.45 xlO 7 units/mg protein and less than 40 ng lipopolysaccharide/mg protein. Human recombinant IL-la (pi 5) was purchased from Genzyme, Haverhill, UK, and IL-2 and penicillin/streptomycin were purchased from Boehringer Mannheim, Mannheim, FRG. Iloprost was a gift from Schering AG, Weesp, The Netherlands. A crude preparation of endothelial cell growth factor was prepared from bovine brain as described by Maciag et al. 14 Human serum was obtained from a local blood bank and was prepared from fresh blood of healthy donors, pooled, and stored at 4°C; the serum was not heat inactivated before use. Newborn calf serum was obtained from GIBCO, Grand Island, N.Y., and heat inactivated before use (30 minutes, 56°C). Heparin was purchased from Leo Pharmaceuticals, Weesp, The Netherlands, and pyrogen-free human serum albumin was from the Red Cross Central Blood Transfusion Laboratory, Amsterdam, The Netherlands. Horseradish peroxidase was obtained from Sigma Chemical Co., St. Louis, Mo., forskolin from Hoechst, La Jolla, Calif., and isobutyl methylxanthine (IBMX) from Janssen Chimica, Beerse, Belgium. Aspirin was purchased from Merck AG, Darmstadt, FRG; a stock solution of aspirin buffered with an equimolar amount of NaHCO 3 was prepared immediately before the experiment and diluted in the culture medium. Carbon-14-labeled sucrose ([U- 14 C]sucrose; 552 mCi/mmol) and iodine-125 were purchased from Amersham, Amersham, UK.
Preparation and Iodination of Low Density Lipoprotein
Low density lipoprotein (LDL) was isolated from fresh serum prepared from the blood of healthy volunteers by gradient ultracentrifugation according to the method of Redgrave et al. 15 Iodination of LDL was performed by the [ 125 I]iodine monochloride method described by Bilheimer et al. 16 After iodina- 
Culture of Endothelial Cells
Endothelial cells from human umbilical artery 18 and from human aorta and vena cava 19 were isolated by collagenase treatment and characterized as described previously. The cells were cultured on fibronectin-coated dishes in Medium-199 supplemented with 10% human serum, 10% newborn calf serum, 150 /ig/ml crude endothelial cell growth factor, 5 units/ml heparin, and penicillin/streptomycin at 37°C in an atmosphere of 5% CO2/95% air.
For passage studies, confluent monolayers of endothelial cells from umbilical artery, aorta, or vena cava were released with trypsin-EDTA and seeded at high density (twice the confluent density) on fibronectin-coated polycarbonate filters of the Transwell system and cultured as described previously. The cells attached rapidly to the filter; unattached cells were removed after 4 hours. The culture medium was replaced every other day.
Passage Experiments
Endothelial cells cultured on filters were used between 4 and 6 days after seeding. Umbilical artery endothelial cells were normally used after one passage, but similar results were also obtained with these cells after two passages. Aortic endothelial cells were used after two ( Figure ]sucrose through human endothelial cell monolayers was measured as described earlier. 910 In short, endothelial cell monolayers were cultured on porous membranes (0.33-cm 2 diameter, 3-/Ltm pore size) for 4-6 days to form a tight monolayer. Before the experiment, cells were incubated for 1 hour in Medium-199 supplemented with 20% human serum. At the start of the experiment, 5 ;u,g/ml horseradish peroxidase, 25 ^g/ml I25 I-LDL, or 1.2 nmol/ml [ M C]sucrose in Medium-199 with 20% human serum was added to the upper compartment of the Transwell system. At various time intervals, samples were taken from the lower compartment (at the other side of the endothelial monolayer), and an equal amount of Medium-199 and 20% human serum was replaced in this compartment. All passage experiments were performed in triplicate. The peroxidase concentration was determined in each sample as previously described. 9 Passage rates are expressed as nanograms per hour per square centimeter or nanograms per where PC EC represents the PC of the endothelial cell monolayer, PC F the PC of the empty filter, and PC E C + F the PC determined for the filter and endothelial cells together. The PC F was determined at 37°C under identical conditions with separate fibronectin-coated filters that had been preincubated in serum-containing culture medium for 24 hours.
Transendothelial Electric Resistance
The transendothelial electric resistance was measured as previously described. 9 In short, an alternating current (50 fiA) was passed across the monolayer (one pulse every minute). The measured electric potential difference was used to calculate the electric resistance by Ohm's law.
Assay of 6-Keto-Prostaglandin-F) a
The prostacyclin metabolite 6-keto-prostaglandin F la (6-keto-PGF la ) was assayed by radioimmunoassay (Amersham). Human umbilical artery endothelial cells (confluent, primary, or subcultured once) in 2-cm 2 wells were washed with Medium-199 and incubated for 30 minutes in Medium-199 supplemented with 0.03% human serum albumin. Hereafter, a sample was taken from the medium to determine basal 6-keto-PGF )o production in each well. A small amount of medium with or without TNF-a (final concentration, 500 units/ml) or histamine (final concentration, 10" 5 M) was subsequently added, and after 10 and 60 minutes' incubation, samples were taken from the medium. Samples were stored at -80°C until the assay of 6-keto-PGF] a was performed. Total 6-keto-PGF la concentration was determined in each sample and corrected for the basal production in each well before stimulation.
Extraction and Assay of Cyclic AMP
Extraction and assay of cyclic AMP was performed according to Adams-Brotherton et al 21 with some modifications. Confluent endothelial cell monolayers cultured in 5-cm 2 wells were incubated in Medium-199 supplemented with 20% human serum 1 hour before the incubation period. Fifteen minutes before the incubation period, IBMX (final concentration, 1 mM) was added to the medium. At the start of the incubation period, stimulatory agents were added to the medium and incubations were continued for another 15 minutes at 37°C. Subsequently, 0.6 ml ice-cold 5% trichloroacetic acid was added to each well. A small amount of tritium-labeled cyclic AMP (Amersham) was added to each well to monitor the recovery of cyclic AMP during purification. After 10 minutes on ice, the extracts were collected and placed on a small DOWEX-50 WX4 (Fluka AG, Buchs, Switzerland) column. Columns were washed with 0.05N HC1, and cyclic nucleotides were eluted with IN HC1 and then air dried. The concentration of cyclic AMP was determined by radioimmunoassay (Amersham) and corrected for the recoveries of cyclic AMP in the various samples.
Fluorescence Microscopy
Confluent endothelial cell monolayers cultured on coverslips were stimulated with or without 500 units/ml TNF-a in complete culture medium for the indicated time intervals. The medium was aspirated, and cells were directly fixed in 3% paraformaldehyde in phosphate-buffered saline (PBS) for 15 minutes time (h) followed by 2 minutes in 0.1% Triton X-100 in PBS at 4°C. Cells were gently washed with PBS. To visualize F-actin, the cells were incubated with 3.3 xlO" 8 M rhodamine-phalloidin in PBS for 30 minutes. After the cells were stained, they were gently washed, p-phenylenediamine was added to each coverslip, and the cells were viewed by use of a fluorescence microscope (Leitz Laborlux D, Wetzlar, FRG). Photomicrographs were taken with Ilford HP5-film.
Statistics
Statistical significance (p<0.05) was evaluated by Wilcoxon's t test for matched data.
Results
Effect of Inflammatory Mediators on Endothelial Permeability
Human umbilical artery, aortic, and vena cava endothelial cells cultured on porous filters form a tight monolayer, with an average transendothelial electric resistance of 17 Hem 2 (umbilical artery), 10 ft-cm 2 (aorta), and 8 Hem 2 (vena cava). The passage rate of peroxidase through human umbilical artery endothelial cell monolayers was comparable with the passage rate through human vena cava and aortic endothelial monolayers and 40-fold to 60-fold lower than through niters without an endothelial monolayer. The passage rate of 125 I-LDL through aortic endothelial cell monolayers was, on average, fourfold lower than through monolayers of umbilical artery endothelial cells and 80-fold to 300-fold lower than through empty filters. I-LDL, respectively, had been passed through the monolayer into the lower compartment. We calculated that under these conditions the permeability coefficients for sucrose, peroxidase, and LDL were 22.6xlO" 6 cm/sec, 1.74xlO" 6 cm/sec, and 0.57XlO" 6 cm/sec, respectively. Addition of 500 units/ml TNF-a had no significant effect on the passage of these molecules (Figure 1 ). Because we had demonstrated previously that the passage of LDL and peroxidase was influenced in a parallel way by vasoactive agents, 10 peroxidase was used in further experiments to determine endothelial permeability.
With addition of 500 units/ml TNF-a to umbilical artery endothelial cell monolayers, a biphasic change in permeability was observed (Figure 2) . During the first hours of incubation with TNF-a, a concentration-dependent decrease in peroxidase passage was observed (Figures 2 and 3A) , whereas after a 24-hour incubation a concentration-dependent increase was observed (Figures 2 and 3B) . The transendothelial electric resistance decreased to 72±16% of the original values after a 24-hour incubation with 500 units/ml TNF-a (mean±SD, seven different cultures). These changes in permeability were specifically induced by TNF-a. When the TNF-a preparation was inactivated by heating for 10 minutes at 90°C before addition, no change in permeability was observed.
The difference in response to TNF-a between umbilical artery and aortic endothelial cells was not due to a difference in subculturing because early- passage aortic endothelial cell monolayers also did not respond to TNF-a ( Figure 4, Table 1 ), a response similar to that of endothelial cells after six passages (Figure 1 ). This lack of response was not due to insensitivity of aortic endothelial cells for TNF-a because TNF-a induced a threefold to sixfold increase in the production of urokinase-type plasminogen activator by these cells (not shown; see Reference 22). Table 1 summarizes the effects of TNF-a on the permeability of human endothelial cell monolayers. The permeability of vena cava endothelial cells increased slightly after a 24-hour incubation with TNF-a ( Table 1) .
Involvement of Prostacyclin in the Effects of Tumor Necrosis Factor-a
We 23 and other investigators 24 have previously observed that addition of the stable prostacyclin analogue iloprost (10 /iM) induces a 30% reduction of the passage rate of peroxidase. Because TNF-a can stimulate prostacyclin production in various types of cells by direct activation of phospholipase A 2 , 25 > 26 we investigated whether TNF-a temporarily decreased the endothelial permeability in umbilical artery endothelial cells by inducing the release of prostacyclin. As shown in Table 2 , TNF-a as well as histamine stimulated prostacyclin production by primary cultures of these endothelial cells within 10 minutes, as measured by the accumulation of 6-keto-PGF la . This increase was found both in umbilical artery and vein endothelial cells (seven different cultures). However, with confluent cells that had been subcultured once, the prostacyclin production over a 1-hour period by unstimulated cells was below the level of detection and remained so after stimulation with TNF-a (four independent cultures). Because the cells used for the permeability studies had been subcultured once, it is unlikely that TNF-a decreased the permeability of umbilical artery endothelial cell monolayers via the production of prostacyclin. To further exclude the involvement of prostacyclin or other prostaglandins, the monolayers were preincubated with the cyclooxygenase inhibitor aspirin. As shown in Table  3 , aspirin did not prevent the decrease in endothelial cell permeability induced by TNF-a. This strengthens the conclusion that the reduction of permeability by TNF-a is not due to increased production of prostacyclin or other prostaglandins.
Involvement of Cyclic AMP in the Effects of Tumor Necrosis Factor-a
An increase in cellular cyclic AMP concentration results in a marked decrease in endothelial perme- Figure 4 shows this for human aortic endothelial cells to which forskolin was added to increase the cellular cyclic AMP concentration. In human umbilical artery endothelial cells, the peroxidase passage in the presence of 25 /AM forskolin is one fifth of control values on average. 23 Therefore, we investigated whether TNF-a directly affected the cyclic AMP concentration of umbilical artery endothelial cells. When the cells were stimulated for 15 minutes with forskolin alone, virtually no increase of the cyclic AMP concentration could be observed, whereas incubation with IBMX alone resulted in a twofold increase of the cyclic AMP concentration. The presence of both agents appeared to be necessary for a marked and sustained increase of the cyclic AMP concentration. However, substitution of either forskolin or IBMX for TNF-a did not result in an increase of cyclic AMP (Table 4) .
Furthermore, addition of TNF-a to endothelial cells in the presence of forskolin resulted in an additional decrease of the passage rate of peroxidase (Table 3) . Hence, it is likely that the temporary decrease of permeability induced by TNF-a in umbilical artery endothelial cells proceeds by a cyclic AMP-independent mechanism.
Effects of Tumor Necrosis Factor-a on Actin Configuration
Changes in endothelial cell permeability are often associated with a change in the configuration of the cytoskeleton, in particular in the cellular distribution of F-actin. Human umbilical artery endothelial cells in a confluent monolayer are flat, closely apposing cells with prominent stress fibers that contain F-actin, as visualized by staining with rhodamine-phalloidin ( Figure  5A ). F-actin was also present in the peripheral zones of the cells. Treatment of these cells with TNF-a (500 units/ml) resulted in a time-dependent alteration of the configuration of the cytoskeleton. After 30-60 minutes' exposure to TNF-a, the F-actin staining of the stress fibers was less prominent (two of four tested cultures) or largely disappeared (two of four experiments), as depicted in Figure 5B . The cells remained closely apposed. After 30-60 minutes' treatment with TNF-a, the peripheral F-actin staining remained similar or occasionally became more pronounced. After 24 hours' exposure to 500 units/ml TNF-a, small gaps between the cells became visible ( Figure 5C ), while the stress fibers became clearly visible again.
Discussion
In this study we have evaluated the effects of TNF-a on the barrier function of human aortic and umbilical artery endothelial cell monolayers. Endothelial cells were cultured on porous filters. They form a tight monolayer characterized by the presence of tight junctions, an adequate electric resistance, molecular sieving characteristics, and a response to vasoactive substances.
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We have reported here that TNF-a did not increase the permeability of early-passage human aortic endothelial cell monolayers. This was surprising because several investigators have shown that TNF-a induces a large increase in the permeability in perfused ovine lung and in animal aortic endothelial cell monolayers in vitro. 1112 On the other hand, Moser et al 13 reported that incubation of human endothelial cell monolayers with low concentrations of TNF-a did not result in an increased albumin passage. Three mechanisms may underlie the difference between animal studies and the in vitro data with human endothelial cells: 1) In vivo, TNF-a may not directly act on the endothelial permeability, but via activation of polymorphonuclear leucocytes. have lost their ability to respond. Because the permeability of cultured ovine and bovine aortic endothelial cell monolayers is still markedly increased on incubation with TNF-a, 1112 species differences seem likely to be responsible for the difference in this specific reaction after exposure to TNF-a. Confluent cultures grown in 2-cm 2 wells were used for the assay of 6-keto-prostaglandin F la (6-keto-PGF la ). Cells were incubated, and prostacyclin production was calculated as described in "Methods." Values represent mean±SD of six determinations performed with three different cultures.
TNF, tumor necrosis factor.
Although we found no significant effect of TNF-a on the permeability of human aortic endothelial cells, small effects were observed on the permeability of Human umbilical artery endothelial cells (after one passage) were grown to confluence in 5-cm 2 wells. Isobutyl methylxanthine (IBMX, 1 mM) was added 15 minutes before the incubation period. Forskolin (25 fiM) and tumor necrosis factor (TNF)-a (500 units/ml) were added to the culture medium after 15 minutes. Extraction and determination of cyclic AMP were performed as described in "Methods." Values represent mean±SD of six determinations performed in three independent experiments. human umbilical artery endothelial cells at high TNF-a concentration (500 units/ml). Instead of an increase in permeability, these cells responded with a temporary decrease in permeability during the first hours of TNF-a exposure. With prolonged incubation, a small increase was observed, which may be related to a reorganization of the cell monolayer. This is in line with previous observations of Stolpen et al 28 and may be a reflection of an early angiogenesis response, as TNF-a can induce angiogenesis. 29 -30 It is of interest to note that early-passage human aortic endothelial cells did not show an increase in permeability after TNF-a exposure, whereas subcultured aortic and vein cells (compare Figure 1 and Table 1 ) tended to show a small increase after prolonged incubation with 500 units/ml TNF-a.
Incubation of primary umbilical artery endothelial cells for short periods of time (10 minutes) with 500 units/ml TNF-a resulted in an increased release of prostacyclin. This effect is rapid and represents another effect of TNF-a on prostacyclin production, independent of the long-term increase of prostacyclin production probably by induction of cyclooxygenase, which has been reported by other investigators. 31 - 33 The effect of TNF-a on immediate prostacyclin release could only be demonstrated in primary cultures of endothelial cells. Although cells that have been subcultured once could be stimulated by histamine or thrombin, no response of prostacyclin production was observed after 10 minutes' incubation with TNF-a. We have investigated whether prostacyclin is involved in the mechanism of the passage process because it can induce cyclic AMP in endothelial cells, 21 -3435 and an increase of cyclic AMP in endothelial cells is paralleled by a decrease of the protein passage rate. 1027 However, the reduction of the passage rate after 2 hours' incubation with TNF-a cannot be explained by the involvement of prostacyclin because 1) we always used cells that produced very little prostacyclin because they had been passaged once and 2) the reduction of the passage rate was also observed in the presence of the cyclooxygenase inhibitor aspirin. Furthermore, TNF-a did not affect the cyclic AMP concentration either directly or in the presence of the phosphodiesterase inhibitor IBMX.
The adenylate cyclase activator forskolin induces a large increase of cyclic AMP in endothelial cells. In the presence of 25 fjM forskolin, which induced a maximal cyclic AMP-dependent reduction in permeability, 23 TNF-a was still able to induce a transient reduction of the passage rate of peroxidase. This finding supports the idea that this reduction is cyclic AMP independent. In addition, it suggests that the results are not due to a relative high basal level of the passage rate through cultured human endothelial cell monolayers on artificial surfaces because the passage rates in the presence of forskolin approximate physiological values.
Gap formation between endothelial cells is induced by cellular contraction 38 -41 and is caused by the interaction between actin and myosin, which are structural proteins present in the stress fibers and in the cell periphery. This cellular contraction is regulated via the phosphorylation of the myosin light chain by the calcium-calmodulin complex. 42 Stress fibers are found in arterial cells, both in vivo under various conditions 43 - 44 and in vitro. 45 Stress fibers have been postulated to play a role in cellular contraction. 46 - 47 We have shown previously that treatment of human endothelial cells with forskolin results in a considerable loss of stress fibers in many of the cells. 23 Treatment of the endothelial monolayers with TNF-a (500 units/ml) for 1 hour results in a less prominent but visible alteration of the cytoskeleton. However, it remains to be established whether the disappearance of stress fibers is only the result of a general dissociation of actin and myosin interaction or whether it plays a direct, active role in the regulation of endothelial cell permeability.
In summary, in this report we have shown that high concentrations of TNF-a induce an increase of the prostacyclin production in primary human endothelial cells. During short-term incubations, TNF-a induces a reduction of the passage rate of macromolecules through monolayers of human umbilical artery endothelial cells, a reduction that seems to be unrelated to a change in the cyclic AMP concentration. On prolonged incubation with TNF-a, the permeability of these monolayers increased. However, these effects of TNF-a on endothelial permeability were only significant at high concentrations of TNF-a, which are maintained in vivo only for short periods. Furthermore, no increase in the permeability of human aortic endothelial cell monolayers was observed. Therefore, it is unlikely that TNF-a plays a role in the increased permeability that has been found in human arteriosclerotic lesions.
